FindTrial
Sign In

Analysis of the long-term clinical efficacy and reasons for failure of the ABG II femoral stem prosthesis

Analysis of the long-term clinical efficacy and reasons for failure of the ABG II femoral stem prosthesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081328
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip arthroplasty

Interventions

Case series (ABG II Prosthesis Group):None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The patient was treated with an ABG II prosthesis during the surgical procedure; (2) The patient had access to all clinically relevant information at the postoperative follow-up visit;

Exclusion criteria

Exclusion criteria: (1) Patients with clinical information obtained from postoperative follow-up <10 years; (2) Patients with missing basic information;

Design outcomes

Primary

MeasureTime frame
Prosthesis survival rate;Revision rate and reasons for revision of ABG II prosthesis;—

Secondary

MeasureTime frame
SF-12 Quality of Life Scale score;CCI comorbidity scores;Timing of refurbishment incidents, measures to address refurbishment;—

Countries

China

Contacts

Public ContactXiaojun Shi

West China Hospital, Sichuan University

shixjoint@scu.edu.cn+86 189 8060 6872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026